UniDoc Provides Update on Marketing Engagement
UniDoc Health has provided an update on its marketing engagement with Rumble Strip Media. The company spent approximately $3.84 million on investor relations marketing services since April 2024, successfully converting over 90% of outstanding warrants into $8.8 million in gross proceeds.
The company has begun commercial sales with purchase orders for 16 H3 Health Cube booths from four customers. Three booths have been delivered, with revenue expected from two units in Q4. UniDoc has raised approximately $13.4 million since 2021 through private placements ($3.7M) and convertible securities ($9.7M).
While not yet cashflow positive, UniDoc allocates funds primarily to general administration ($1.4M) and investor relations ($3.4M). The company expects investor relations marketing expenses to decrease significantly as operational expenditures increase in coming quarters, reflecting its transition from development to sales phase.
UniDoc Health ha fornito un aggiornamento sul suo coinvolgimento nel marketing con Rumble Strip Media. Da aprile 2024, l'azienda ha speso circa 3,84 milioni di dollari per servizi di marketing nelle relazioni con gli investitori, riuscendo a convertire con successo oltre il 90% dei warrant in sospeso in 8,8 milioni di dollari di proventi lordi.
L'azienda ha avviato le vendite commerciali con ordini d'acquisto per 16 H3 Health Cube booth da parte di quattro clienti. Tre booth sono stati consegnati, con ricavi previsti da due unità nel quarto trimestre. UniDoc ha raccolto circa 13,4 milioni di dollari dal 2021 tramite collocamenti privati (3,7 milioni) e titoli convertibili (9,7 milioni).
Anche se non ancora in positivo dal punto di vista del flusso di cassa, UniDoc destina principalmente i fondi all'amministrazione generale (1,4 milioni) e alle relazioni con gli investitori (3,4 milioni). L'azienda prevede una significativa riduzione delle spese di marketing per le relazioni con gli investitori man mano che aumenteranno le spese operative nei prossimi trimestri, riflettendo la sua transizione dalla fase di sviluppo a quella di vendita.
UniDoc Health ha proporcionado una actualización sobre su compromiso de marketing con Rumble Strip Media. La empresa ha gastado aproximadamente 3,84 millones de dólares en servicios de marketing para relaciones con inversores desde abril de 2024, logrando convertir con éxito más del 90% de las garantías pendientes en 8,8 millones de dólares en ingresos brutos.
La compañía ha iniciado ventas comerciales con órdenes de compra para 16 H3 Health Cube booths de cuatro clientes. Se han entregado tres booths, y se esperan ingresos por dos unidades en el cuarto trimestre. UniDoc ha recaudado aproximadamente 13,4 millones de dólares desde 2021 a través de colocaciones privadas (3,7 millones) y valores convertibles (9,7 millones).
Aunque aún no es rentable en términos de flujo de caja, UniDoc destina principalmente fondos a la administración general (1,4 millones) y a las relaciones con inversores (3,4 millones). La empresa espera que los gastos de marketing para relaciones con inversores disminuyan significativamente a medida que aumenten los gastos operativos en los próximos trimestres, reflejando su transición de la fase de desarrollo a la de ventas.
UniDoc Health가 Rumble Strip Media와의 마케팅 협력에 대한 업데이트를 제공했습니다. 회사는 2024년 4월 이후 투자자 관계 마케팅 서비스에 약 384만 달러를 지출했으며, 미결제 워런트의 90% 이상을 성공적으로 전환하여 880만 달러의 총 수익을 창출했습니다.
회사는 4명의 고객으로부터 16개의 H3 Health Cube 부스 구매 주문을 받아 상업 판매를 시작했습니다. 세 개의 부스가 배송되었으며, 4분기에 두 대에서 수익이 예상됩니다. UniDoc은 2021년 이후 사모 배정(370만 달러)과 전환 증권(970만 달러)을 통해 약 1340만 달러를 조달했습니다.
아직 현금 흐름이 긍정적이지는 않지만, UniDoc은 주로 일반 관리비(140만 달러)와 투자자 관계(340만 달러)에 자금을 할당하고 있습니다. 회사는 향후 분기 동안 운영 비용이 증가함에 따라 투자자 관계 마케팅 비용이 크게 감소할 것으로 예상하며, 이는 개발 단계에서 판매 단계로 전환 중임을 반영합니다.
UniDoc Health a communiqué une mise à jour concernant son engagement marketing avec Rumble Strip Media. Depuis avril 2024, la société a dépensé environ 3,84 millions de dollars en services marketing pour les relations investisseurs, réussissant à convertir plus de 90 % des bons de souscription en cours en 8,8 millions de dollars de recettes brutes.
La société a lancé ses ventes commerciales avec des commandes pour 16 stands H3 Health Cube provenant de quatre clients. Trois stands ont été livrés, et des revenus sont attendus pour deux unités au quatrième trimestre. UniDoc a levé environ 13,4 millions de dollars depuis 2021 via des placements privés (3,7 M$) et des titres convertibles (9,7 M$).
Bien que la société ne soit pas encore positive en termes de flux de trésorerie, UniDoc alloue principalement ses fonds à l'administration générale (1,4 M$) et aux relations investisseurs (3,4 M$). Elle prévoit une diminution significative des dépenses marketing liées aux relations investisseurs à mesure que les dépenses opérationnelles augmenteront dans les prochains trimestres, reflétant sa transition de la phase de développement à la phase de vente.
UniDoc Health hat ein Update zu seiner Marketingzusammenarbeit mit Rumble Strip Media bereitgestellt. Das Unternehmen hat seit April 2024 rund 3,84 Millionen US-Dollar für Marketingdienstleistungen im Bereich Investor Relations ausgegeben und dabei erfolgreich über 90 % der ausstehenden Warrants in 8,8 Millionen US-Dollar Bruttoerlöse umgewandelt.
Das Unternehmen hat mit dem Verkauf begonnen und Bestellungen für 16 H3 Health Cube Stände von vier Kunden erhalten. Drei Stände wurden ausgeliefert, und Umsätze aus zwei Einheiten werden im vierten Quartal erwartet. UniDoc hat seit 2021 etwa 13,4 Millionen US-Dollar durch Privatplatzierungen (3,7 Mio.) und wandelbare Wertpapiere (9,7 Mio.) aufgenommen.
Obwohl noch nicht cashflow-positiv, verwendet UniDoc die Mittel hauptsächlich für allgemeine Verwaltungskosten (1,4 Mio.) und Investor Relations (3,4 Mio.). Das Unternehmen rechnet damit, dass die Ausgaben für Investor-Relations-Marketing deutlich zurückgehen, während die operativen Ausgaben in den kommenden Quartalen steigen, was den Übergang von der Entwicklungs- zur Verkaufsphase widerspiegelt.
- First commercial sales achieved with delivery of 3 H3 Health Cube booths
- Purchase orders secured for 16 H3 Health Cube booths from 4 different customers
- Successful warrant conversion campaign raised $8.8M (90% conversion rate)
- Revenue recognition expected in Q4 2025 for 2 booth deliveries
- Company not yet cashflow positive - operations cannot be sustained from revenue alone
- High marketing expenses: $3.84M spent on investor relations services
- Heavy reliance on equity financing and warrant exercises for operations
- Majority of raised funds ($8.8M) going to administrative costs ($1.4M) and investor relations ($3.4M) rather than product development
VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media Inc. ("Rumble").
Further to the Company's news release of April 3, 2025, the Company believes that its renewed engagement of Rumble is in compliance with Policy 7.2 of the Canadian Securities Exchange (the "CSE") as the Company believes that the renewed engagement of Rumble is consistent with its financial resources and level of operations for the reasons outlined herein.
Since its engagement with Rumble started in April 2024, the Company has expended approximately
While the Company has begun commercial sales, and expects to increase its marketing budget for product awareness in the coming periods, the Company is not yet cashflow positive and cannot sustain operations from revenue alone. Since inception, it has relied on raising funds through the issuance of equity and exercise of in-the-money warrants, and will need to continue to do so going forward. The Company has raised a total of approximately
Further, the Company is pleased with its transition from development to sales and is extremely pleased that it expects to report its first revenue in fiscal Q4, which validates the efficacy of its product and buy-in from consumers. To date, the Company has received purchase orders from four separate arm's length end customers for an aggregate of 16 H3 Health Cube booths (two of such purchase orders came through a related party reseller, UniCheck S.r.l.), and has completed delivery of three of these booths. The Company expects to record revenue in Q4 related to two of these booths delivered to its reseller, UniCheck S.r.l. The Company donated the third booth to the end customer, and therefore does not expect to record corresponding revenue.
In light of its increase in operations, commencement of commercial sales, and successful financing activities, the Company believes that its investor relations marketing expenditures are both necessary and proportionate with both its level of operations and financial resources. That notwithstanding, given the natural long sales cycle for procuring and executing on sales in multiple health jurisdictions, there is a lag effect between marketing timing and sales timing that is currently normalizing as purchase are being fulfilled. Management expects investor relations marketing expenditures to significantly decrease and operational expenditures to significantly increase over the coming quarters.
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.comand signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward- looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the anticipated effectiveness of Rumble's investor awareness campaigns, the value of such services to the Company, the Company's anticipated future marketing and operational expenditures, and the sales cycles of the Company's products.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated September 30, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward- looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE: UniDoc Health Corp.
View the original press release on ACCESS Newswire
FAQ
How much revenue did UniDoc Health (UDOCF) generate from H3 Health Cube sales in 2025?
How many H3 Health Cube orders has UniDoc (UDOCF) received as of April 2025?
What was the return on UniDoc's (UDOCF) marketing investment through Rumble Strip Media in 2024-2025?
How much capital has UniDoc Health (UDOCF) raised since 2021?
Will UniDoc (UDOCF) continue its high marketing spend with Rumble Strip Media?
